Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Tax Provisions (2023)

Contineum Therapeutics (CTNM) has 1 years of Tax Provisions data on record, last reported at -$150000.0 in Q4 2023.

  • For Q4 2023, Tax Provisions changed N/A year-over-year to -$150000.0; the TTM value through Sep 2024 reached -$150000.0, changed N/A, while the annual FY2023 figure was $450000.0, N/A changed from the prior year.
  • Tax Provisions reached -$150000.0 in Q4 2023 per CTNM's latest filing, down from -$100000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $700000.0 in Q2 2023 and bottomed at -$150000.0 in Q4 2023.